Search research articles
Contact Us
Filters
Showing results (191-200 of 317) with videos related to
Page
of 32
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>
C N Owen, A N Shoushtari, D Chauhan, et al.
Journal for Immunotherapy of Cancer
|
December 2, 2020
Comprehensive analysis of cutaneous and uveal melanoma liver metastases
Esmee P Hoefsmit, Elisa A Rozeman, Trieu My Van, et al.
Annals of Surgical Oncology
|
October 14, 2025
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Scandinavian Journal of Immunology
|
March 31, 2016
Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets
O Klein, F Ngo-Nyekel, T Stefanache, et al.
Annals of Surgical Oncology
|
January 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma
Alaa Embaby, Sanne C F A Huijberts, Liqin Wang, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
A H Boekhout, A Rogiers, K Jozwiak, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2014
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2023
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Adriana Hepner, Judith M Versluis, Roslyn Wallace, et al.
Page
of 32
Search research articles
Search
Showing results (191-200 of 317) with videos related to
Sort By:
Page
of 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>
C N Owen, A N Shoushtari, D Chauhan, et al.
Journal for Immunotherapy of Cancer
|
December 2, 2020
Comprehensive analysis of cutaneous and uveal melanoma liver metastases
Esmee P Hoefsmit, Elisa A Rozeman, Trieu My Van, et al.
Annals of Surgical Oncology
|
October 14, 2025
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Scandinavian Journal of Immunology
|
March 31, 2016
Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets
O Klein, F Ngo-Nyekel, T Stefanache, et al.
Annals of Surgical Oncology
|
January 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma
Alaa Embaby, Sanne C F A Huijberts, Liqin Wang, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
A H Boekhout, A Rogiers, K Jozwiak, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2014
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2023
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Adriana Hepner, Judith M Versluis, Roslyn Wallace, et al.
Page
of 32